ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.590
+0.040 (2.58%)
May 9, 2025, 1:54 PM - Market open
ProQR Therapeutics Employees
ProQR Therapeutics had 166 employees as of December 31, 2024. The number of employees increased by 10 or 6.07% compared to the previous year.
Employees
166
Change (1Y)
10
Growth (1Y)
6.07%
Revenue / Employee
$127,710
Profits / Employee
-$196,414
Market Cap
167.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PRQR News
- 1 day ago - ProQR Announces First Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 7 days ago - ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference - GlobeNewsWire
- 8 days ago - ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 - GlobeNewsWire
- 25 days ago - ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth - GlobeNewsWire
- 2 months ago - ProQR Announces Year End 2024 Operating and Financial Results - GlobeNewsWire
- 5 months ago - ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist - GlobeNewsWire
- 6 months ago - ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 7 months ago - ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire